EMN · Eastman Chemical Co
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Sequential adjusted EBIT margin improvement | 350 | 2Q2026 | — |
| Adjusted EBIT margin non-GAAP | 20% | First Quarter 2026 | — |
|
|
|||
| sales volume/mix | 10% | first quarter 2026 | — |
| Total earnings before interest and taxes excluding non-core items non-GAAP | $200M | First Quarter 2026 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Earnings before interest and taxes 188M
+3M Cost of sales impact from restructuring activities
+9M Asset impairments, restructuring, and other charges, net
= Total earnings before interest and taxes excluding non-core items 200M
|
|||
| Total segment EBIT excluding non-core items non-GAAP | $238M | First Quarter 2026 | — |
|
|
|||
| Total segment EBIT excluding non-core items margin non-GAAP | 10.9% | First Quarter 2026 | — |
| Additives & Functional Products Adjusted EBIT non-GAAP | $94M | Q4 2025 | — |
| Advanced Materials Adjusted EBIT non-GAAP | $59M | Q4 2025 | — |
| Chemical Intermediates Adjusted EBIT non-GAAP | -$28M | Q4 2025 | — |
| Fibers Adjusted EBIT non-GAAP | $67M | Q3 2025 | — |
| Net debt non-GAAP | $4.22B | December 31, 2025 | — |
GAAP → non-GAAP reconciliationGAAP Total borrowings $4.79B
-$566M Less: Cash and cash equivalents
= Net debt $4.22B
|
|||
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
EMN
this stock
Eastman Chemical Co
|
$8.31B | +14.4% | -6.7% | 18.9 | 4.9% |
|
LIN
Linde PLC
|
$223.74B | +14.8% | +3.0% | 31.3 | 1.1% |
|
AIQUF
L Air Liquide SA /Fi
|
$126.15B | +5.6% | — | — | 0.0% |
|
SHW
Sherwin Williams Co
|
$83.55B | +6.4% | +2.1% | 31.8 | 2.6% |
|
ECL
Ecolab Inc.
|
$80.15B | +9.2% | +2.2% | 38.4 | 1.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| EMN | -1.4% | +4.4% | +4.9% | +4.4% | +14.4% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | -1.9% | +1.4% | -8.5% | +1.4% | +1.6% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.